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Background: It is difficult to achieve a margin-negative resection (R0) for non-small cell lung cancer (NSCLC)
patients with infiltration of the pulmonary artery. We report our experience of the pulmonary artery reconstruction
with regard to long-term survival.
Methods: Clinical records of 118 patients with NSCLC who underwent partial or circumferential pulmonary artery
resection during a 21-year period were reviewed retrospectively. Techniques and survival outcomes were analyzed.
Results: We performed 22 pulmonary artery sleeve resections, 51 reconstructions by autologous pericardial patch,
36 tangential resections, 3 left main pulmonary artery (PA) angioplasties during pneumonectomy without
cardiopulmonary bypass, and 6 by only preserving the apical and anterior (1st) branch of pulmonary arterial trunk.
In 41 patients, bronchial sleeve resection was associated; in 7 cases, superior vena cava reconstruction was also
required. Thirty-one patients received induction therapy. Thirteen patients had stage IB disease, 41 stage II, 53 IIIA,
and 11 IIIB. Ninety-three patients had squamous cell carcinoma, 22 adenocarcinoma, 2 mixed and 1 large cell carcinoma.
Negative vascular margins were achieved in all. 5 positive bronchial margins were due to limited lung function. The
analysis of 118 cases yielded follow-up data in 94 cases. The mean follow-up was 70 months (range 1–156 months).
There was no in hospital death, and the overall 5-year survival was 50.2%. Five-year survivals for stages I and II versus III
were 63.9% versus 37.0% (p = 0.0059). Multivariate analysis yielded non-squamous cell carcinoma, stage III and patch
pulmonary arterioplasty as negative prognosis factors. PA reconstruction associated with bronchial sleeve resection was
the positive prognostic factor.
Conclusions: Pulmonary artery resection and reconstruction is feasible and safe, with favorable long-term survival. Our
results support this technique as an effective alternative to selected patients with infiltration of the pulmonary artery,
such as stage I and II and those who proved down-staged from stage III. Accurate preoperative evaluation, precise and
suitable surgical techniques are crucial to achieve good results. Only preserving the anterior and apical pulmonary
arteries and reconstruction of the main pulmonary artery by using the artery conduit technique without cardiopulmonary
bypass in association with left pneumonectomy can be performed successfully. Postoperative anticoagulation
is unnecessary.
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Incidence of non-small cell lung cancer (NSCLC) is con-
tinues to increase in many countries, and NSCLC is the
leading cause of cancer deaths worldwide [1]. Surgical
resection may be curative but complications are often
associated. Pneumonectomy has been considered appro-
priate to achieve cure in patients with the direct invasion
of the pulmonary artery (PA) and/or involvement of
main bronchus. However, it confers significant higher
morbidity and mortality than lobectomy. Pneumonectomy
is also associated with reduced quality of life, especially
when performed on the right side or after induction
chemotherapy [2-4]. These considerations have led to fur-
ther evaluating a better technique. The origin of PA re-
construction and bronchoplasty surgery can be traced to
the end of 1950s. At first, this surgical technique was tech-
nically demanding and used only when pulmonary func-
tion was compromised to preclude pneumonectomy and
its oncologic outcome was in doubt. In the past 2 decades,
many thoracic surgeons have confirmed the feasibility
and effectiveness of this technique and recommended it
should be used when possible. At the present time, recon-
struction of PA can achieve complete cancer resection
while preserving functioning pulmonary tissue, and has a
definite role in the surgical management of lung cancer.
Compared with bronchoplasty, reconstructive proce-
dures of the PA have encountered more difficulties in
gaining acceptance. This is due to fewer studies with a
large series of patients with long-term follow-up and dis-
couraging results in terms of postoperative complica-
tions [5]. We therefore report this retrospective study
with introduction of surgical techniques and long-term
results after 21 years of legitimate doubts and improving
understanding.
Methods
This retrospective cohort study used an electronic data-
base of consecutive patients between 1990 and 2011,
and the study was approved by the China-Japan Friend-
ship hospital Ethics Committee. Patients who underwent
partial or circumferential pulmonary artery resection and
had margin-negative resections at China-Japan Friendship
hospital were eligible. Different non-small cell lung cancer
TNM stage editions existed during the last 21 years. The
data was collected with pathology reports, so we reviewed
the pathological details and use only one standard. That is
7th edition, 2009.
Evaluation
Entry criteria for this study mandated clinical history,
physical examination, computed tomography (CT) scan
with intravenous contrast no more than 1 month before
resection, pulmonary function test, blood gas analysis,
cardiac evaluation, bronchoscopy, abdominal B-ultrasound,cerebral magnetic resonance imaging (MRI), isotopic bone
scanning and basic examinations as usual. Fluorodeoxy-
glucose-position emission tomographies were performed
in selected cases. Patients who had biopsy-proven N2 dis-
ease received neoadjuvant chemotherapy with a cisplatin-
based regimen. Preoperative radiotherapy is not routinely
used at our center. All patients were restaged after neoad-
juvant therapy, and resection was generally reserved for
those who were down-staged. Surgical technique for PA
and bronchial reconstruction was uniform throughout the
study period. Operative mortality was defined as any death
within 30 days of surgery or during the same hospital
admission.
Surgical technique for pulmonary artery resection and
reconstruction
Once proximal and distal control of the PA was obtained,
infiltration area of PA wall was removed sharply. The ar-
tery was reconstructed to reestablish blood flow to the
remaining pulmonary parenchyma. Suturing was com-
pleted with double continuous 5–0 polypropylene sutures.
Tangential arterial resection with direct sutures was car-
ried out when possible (residual arterial caliber, >70%), as
shown in Figure 1. Sometimes the length of the invasion
was long but the width was narrow. To avoid a significant
stenosis, the artery wall was resected along the vertical
axis of PA (around the invasion) and then primary repair
was performed along the horizontal axis, as shown in
Figure 2.
Otherwise, application of autologous pericardial patch
(PA invasion was from 30% to 50%) or circumferential
resection (PA invasion was more than 50%) was per-
formed. The vessel should be carefully preserved with a
sufficient lumen. And the distal occlusive clamp was re-
leased before suture tie to remove air, as shown in
Figure 3.
In a few cases, the pulmonary ateries were intensively
infiltrated below the level of the 1st branch (anterior and
apical pulmonary arteries) by tumor or lymph nodes.
We only kept the 1st branch to perfuse the entire right
or left upper lobe, and then performed bilobectomy
(right middle & lower lobes) or left lower lobectomy, as
shown in Figure 4 and Figure 5. If the space for surgery
was limited and the 1st branch originated more proximal
to heart, we suggest opening pericardial sac to expose
the root of main pulmonary artery. Next, an occlusive
clamp at the root level of main PA can be placed to fa-
cilitate safer control of the inflow. There were 6 patients
who received this surgery, and no evidence of insuffi-
ciency of blood infusion or hypoxemia was found. Post-
operative outcomes were acceptable.
The invasion of the left main PA root occurred quite
infrequently. Cardiopulmonary bypass (CPB) was always
used to control of the main pulmonary’s blood flow.
Figure 1 Tangential arterial resection with direct sutures. A. Left upper lobectomy. Left apical, anterior and lingular arteries were invaded. B.
Left lower lobectomy. Left common basal and superior segmental arteries were invaded. C. Right upper lobectomy. Right truncus anterior and
posterior ascending arteries were invaded. D. Right lower lobectomy. Right common basal and superior segmental arteries were invaded.
Ma et al. Journal of Cardiothoracic Surgery 2013, 8:219 Page 3 of 10
http://www.cardiothoracicsurgery.org/content/8/1/219Another option, the temporary intra-artery conduit tech-
nique, was recommended here. This procedure was used
for 3 patients who underwent left pneumonectomy.
Once the conduit was inserted from the main PA to the
right PA, proximal occlusion of the main PA and distal
occlusion of the right PA were then obtained. Repair of
the defect could be performed after extended resection
of left main PA. Distal occlusion was released first to re-
move air and test if the repair was satisfied. And then
the continuity of the main PA could be regained imme-
diately after conduit was removed from the arterial
lumen. In these 3 cases, control of the main PA blood
flow could be achieved by using this technique without
CPB. This procedure can be performed with less opera-
tive cost, fewer complications, decreased length of stay
and more technical ease. They were proved had no
hemodynamic consequences by trans sternal echocardio-
gram, as shown in Figure 6.Figure 2 The left main pulmonary artery wall was resected along the
repair was performed along the horizontal axis. Left anterior and apicaWe stapled the pulmonary vein first and then injected
1500U of heparin intravenously. Next, two Satinsky
clamps were placed on the proximal and distal PA. The
handles of clamps were positioned facing in the opposite
direction. This position afforded more space for the sur-
geons. The width of the arterial wall is always limited for
angioplasty. Therefore, frozen section of the arterial wall
is necessary to ensure the negative margin. In order to
decrease the PA occlusive time, Rendina and colleagues
reestablished the PA continuity first, when circumferen-
tial resections of the bronchus and artery were both re-
quired [6]. However, we thought this would increase
tension of the sewn PA or PA anastomosis. Thus we per-
formed the bronchus anastomosis with interrupted su-
tures first, followed by the PA resection or anastomosis.
The bronchial anastomosis was covered with an inter-
costal muscle flap. An autologous pericardial patch was
used when the residual PA lumen was narrowed fromvertical axis of main PA (around the invasion) and then primary
l pulmonary arteries were invaded.
Figure 3 Patch and circumferential resection. A. Left apical and anterior arteries were invaded. B. Left apical, anterior, and lingular pulmonary
arteries were all invaded.
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the arterial wall. When the invasion is more than 50%,
we preferred circumferential resection and sleeve anas-
tomosis, protected with mediastinal pleura.
Follow -up
Follow-up information was obtained from several sources,
including telephone interviews with patients or their fam-
ily, Social Security Death Index, clinical letters or letters
from oncologists and other physicians. There were 24
patients unavailable for follow-up at the completion ofFigure 4 Only preserved the truncus anterior (both anterior and apic
lower lobectomy).study. The mean follow-up was 70 months (range 1–
156 months). Patients were followed postoperatively with
chest CT and blood tumor markers every 6 months in the
first 2 years, and yearly there afterwards. We agree that
the use of these markers is not standard in North Amer-
ica, South America or Europe, but the markers are com-
monly used in Asia. Fludeoxyglucose Positron emission
tomography (FDG-PET) was utilized in patients with a
suspicion of metastatic disease or mediastinal involve-
ment: the shortest diameter of the enlarged mediastinal
lymph node was more than 1 centimeter on the chest CT.al pulmonary artery branches) for bilobectomy (Right middle &
Figure 5 Only preserved the anterior and apical pulmonary artery branches for Left lower lobectomy.
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all patients.Statistical analysis
Data were collected and stored with an Excel database
(Microsoft Corp, Redmond, Wash). Overall survival rates
were calculated by using the Kaplan-Meier method and
compared with the Log-rank test. All of the clinical and
pathologic variables with a possible effect on survival were
entered in a multivariate analysis (Cox proportional haz-
ard model) to identify independent prognostic factors.
The statistical analysis was performed with the SAS soft-
ware, version 9.3 (SAS Institute, Cary, NC).Figure 6 Temporary intra pulmonary artery conduit technique was us
of the left pulmonary artery (bifurcation of the main pulmonary artery) wasResults
Between April 1990 and April 2011, 3095 Lung resections
were performed in our department: 364 pneumonecto-
mies, 2150 lobectomies and 220 sleeve lobectomies. The
population of this study was 118 pulmonary artery recon-
structions including 18 dual (broncho-vascular) sleeve
lobectomies, 97 lobectomies and 3 pneumonectomies.
Preoperative data
There were 87 men (75.7%) and 28 women (24.3%). The
mean age was 61 ± 12.2 years. The mean preoperative
FEV1 was 78.5% ± 18%. Percentage of smoker was 80.5%.
37 patients had comorbidities (hypertension n = 21;
arrhythmia n = 3; previous myocardial infarction n = 2;ed for 3 patients who underwent left pneumonectomy. The root
invaded.
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tery atherosclerotic disease n = 1; cerebrovascular disease
n = 2; diabetes n = 8). Induction chemotherapy was carried
out in 31 patients (28 received chemo therapy alone and 3
received chemo radiation therapy). All chemotherapy pro-
tocols were platinum based and the main indication for
neoadjuvant therapy was N2 disease.
Surgical and pathologic data
Thirty-seven resections were performed on the right side
and 81 on the left (3 left pneumonectomies were in-
cluded). Partial PA resections with primary closure were
carried out in 36 (31.3%) patients. Patch pulmonary
arterioplasties were performed in 51 (44.3%). Patches
were made with autologous pericardium. Twenty-two
patients underwent circumferential resection and end-
to-end anastomosis. The apical and anterior pulmonary
artery branches preserved procedures were accomplished
in 6 patients. Bronchial sleeve resection was associated in
41 patients (intercostal muscle was harvested and wrapped
around the bronchial anastomosis). In 7 cases, superior
vena cava reconstructions were also required.
Thirteen patients had stage IB disease, 41were in stage
II, 53 were in IIIA and 11 were in IIIB. Two groups of
stage I and II were combined for survival analysis due to
relatively small numbers. Histological examination showed
that ninety-three patients had squamous cell carcinoma,
22 adenocarcinoma, 2 mixed and 1 large cell carcinoma.
The proportion of squamous cell carcinoma (79.1%) is sig-
nificantly higher than other types.
Postoperative outcome
Although the overall morbidity was 52.2% (n = 60), and
there were no intraoperative deaths. The most frequent
complication, supraventricular arrhythmia, occurred in 29
cases (25.2%). One pulmonary artery thrombosis was
demonstrated by angiography after a left upper sleeve lob-
ectomy with PA end-to-end reconstruction. This patient
underwent successful pneumonectomy (on postoperative
day 3). Two patients with respiratory failure required rein-
tubation on postoperative days 2 and 4, respectively.
Other complications were pulmonary edema (n = 4), atel-
ectasis (n = 5), pneumonia (n = 8), left recurrent laryngeal
neurapraxia (n = 2) and prolonged air leak (n = 11). Long-
term postoperative anticoagulation is not required if no
other disease coexist. Self-compressive leg device is used
to help prevent deep venous thrombosis and pulmonary
embolism. Patients undergoing the temporary intra-artery
conduit technique died because of distant metastasis.
These 3 patients were excluded from the survival analysis.
Long-term outcomes
For the whole population (calculated on 115 patients, 3
left pneumonectomy were not included), the mediansurvival was 68 months (95%CI: 63–77 months); overall
3- and 5-year survival was 60.3% (95%CI: 50.1%-68.9%)
and 50.2% (95%CI: 40.0%-59.5%), respectively (Figure 7).
113 (95.8%) patients received R0 resection. The 5 cases
with positive bronchial margins were due to limited lung
function. They were deemed not to tolerate sleeve pneu-
monectomy. Regarding the recurrence rate (47.8%),
three factors may be responsible. First, 35 patients were
confirmed to have with ipsilateral mediastinal lymph
nodes metastasis (N2). Of these 35, 24 were found be-
tween 1990–2000. PET-CT, mediastinoscopy, and EBUS
(Endobronchial Ultrasound-guided Trans Bronchial Nee-
dle Aspiration) were regularly employed after that. Sec-
ond, five patients developed secondary tracheal tumors
after sleeve lobectomy. There were no sleeve margins
microscopically positive on final pathology. These five sec-
ondary tumors are separate airway tumors, and have iden-
tical histology compare to the original tumor. Third, the
remaining patients with recurrence had both local and
distant disease.
The incidence of complications, nodal involvement,
and gender were found to be independent perioperative
variables related to recurrence after complete surgical re-
section. Odds Ratio estimates are 378.2 (95%CI: 36.5-1000),
28.2 (95%CI: 2.9-276.2) and 6.6 (95%CI: 1.0-43.7), respect-
ively. Locoal regional recurrence is defined as any recur-
rence that occurred with in the ipsilateral hemithorax
including mediastinum or neck area. These could be iso-
lated or part of wide spread (local and distant) recurrent
disease. Six isolate pulmonary nodules of NSCLC were
treated with wedge resection; 7 tracheal recurrences were
managed with endo-tracheal tumor cryotherapy. Two of
them occurred by virtue of positive margins. Five cases
were secondary tumors. Eighteen multiple pulmonary
nodules (10 distant metastasis included) and 21 extra-
thoracic recurrences were managed with chemotherapy, 5
thoracic radiotherapy and 3 brain radiotherapy were asso-
ciated. A patient with isolated adrenal metastasis, one pa-
tient with anterior chest wall recurrence and two isolated
brain metastasis underwent surgical intervention. Among
the 59 late deaths, 4 died from non-tumor associated
causes: 1 myocardial infarction, 1 car accident, 1 stroke, 1
renal failure and pneumonia. The remaining was due to
recurrent disease.
Patients with stage I and II had a significantly better
5-year survival than stage III (63.9% vs. 37.0%, p = 0.0059),
as shown in the Figure 8. No significant differences were
found with respect to age, gender, comorbidities, choice
of reconstruction techniques, and possible associated
bronchoplasty. A trend toward better outcome was ob-
served in patients with squamous cell carcinoma com-
pared with non-squamous cell carcinoma (5-year survival
of 53.8% vs. 37.8%, p = 0.080). Patients without induction
therapy showed a trend toward better outcome compared
Figure 7 Overall survival curve. 5-year survival rate is 50.2% (95%CI: 40.0%-59.5%, calculate on 115 cases).
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Patients with N0 or N1 disease had a better outcome
than N2 disease (55.4% vs. 37.8%, p = 0.093), as shown
in Table 1.
The PA resection and reconstruction procedure asso-
ciated with bronchial sleeve resection was a independ-
ent factor of good outcome. It is a protective factor
(Hazard Ratio = 0.203, p < 0.0001), during multivariate
analysis. While, histology type of non-squamous cell
carcinoma, stage III and patch pulmonary arterioplastyFigure 8 Survival curves by stage (0 = stage I and II, 1 = stage III). Five
(p = 0.0059), calculate on 115 cases.were independent factors of worse outcome (p = 0.0007,
0.0012 and 0.0208 respectively), as shown in Table 2.
Discussion
Reconstruction of the pulmonary artery usually indicates
that tumors or lymph nodes adhere to or invade the PA
in the hilum and preclude complete resection by simple
lobectomy. The PA can be compromised to various de-
grees, from partial filtration to a more extensive and even
circumferential invasion or grow inside of the lumen. This-year survival for stages I and II, versus III were 63.9% versus 37.0%
Table 1 Univariate analysis for 5-year survival
Variable NO % 5-year
survival
(%)
95% CI (%) P value
SDF_LCL SDF_UCL
Gender 0.4340
Male 87 75.7 50.3 38.5 61.1
Female 28 24.3 50.6 30.0 67.4
Age 0.2477
≥65y 64 55.7 45.7 31.9 58.4
<65y 51 44.3 55.8 40.5 68.7
Stage 0.0059
I and II 52 45.2 63.9 48.9 75.6
III 63 54.8 37.0 23.4 50.6
Comorbidity 0.2309
Yes 37 32.2 62.7 44.3 76.5
No 78 67.8 44.6 32.5 56.6
Induction 0.0854
Yes 31 27.0 38.3 20.1 56.3
No 84 73.0 54.8 42.9 65.2
Histologic type 0.0802
Squamous 91 79.1 53.8 42.3 64.0
Non-squamous 24 20.9 37.8 18.4 57.1
Nodal status 0.0933
N0 ~ N1 80 69.6 55.4 43.2 66.0
N2 35 30.4 37.8 20.1 55.4
Reconstruction tech. 0.1723
Tangential R. 36 31.3 57.6 37.8 73.1
Patch 51 44.3 40.0 26.0 53.6
Sleeve 22 19.1 55.3 31.2 74.0
Truncus
preserved
6 5.2 83.3 27.3 97.5
Procedure 0.1462
PA alone 74 64.3 43.1 30.8 54.9
PA + B. sleeve 41 35.6 63.8 46.5 76.8
PA alone = patients only received pulmonary artery reconstruction.
PA + B. sleeve = patients received pulmonary artery reconstruction associated
with bronchial sleeve resection.
Calculated on 115 patients, those who underwent left pneumonectomy with
artery conduit technique (n = 3) were not included.
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techniques, like tangential resection with direct repair,
patch reconstruction, end-to-end anastomosis or inter-
position of a prosthetic conduit [6].
Accurate evaluation of the PA involvement has been
improved with the help of three-dimensional reconstruc-
tions imaging. However, presence of vascular encroach-
ment cannot be defined with interpreting imaging and it
is impossible to make a specific PA reconstructive plan
preoperatively. The most appropriate technique optionof reconstruction is usually chosen during the operation
on the basis of how much the vascular is invaded, and
this crucial decision may take a long time and many ef-
forts. Once face this situation surgeons should be en-
couraged to avoid the easier choice, pneumonectomy.
In our experience and in agreement with others [7,8],
it is much more frequently to perform PA reconstruc-
tion on the left side and for squamous cell carcinoma
(SCC). SCC is more often to be seen in central type
NSCLC because larger bronchi are usually the primary
sites of this type tumor. And it often metastasizes to
hilar lymph nodes early in its course. Compared with
the right side, both superior and posterior side of left
upper bronchus is surrounded by the PA. Due to this
anatomical reason, direct invasion by primary tumor or
metastasis lymph nodes originating in the lung hilum is
more likely to occur on the left side. Similar to loboto-
mies, the 3 pneumonectomies were also on the left side.
In addition, the left recurrent laryngeal nerve is also eas-
ier to be injured compared with right side, care should
be taken when using energy equipment and extra extend
retraction should be avoid.
Induction chemotherapy is usually used for patients
with N2 or chest wall invasion [9], and it is usually more
technically demanding after induction therapy, because
of the deleterious effects on bronchial healing, vascular
fragility and local devasculation. Safety can be guaran-
teed once the proximal PA is clamped. If there was no
enough room to place the clamp, open the cardiac sac
to expose the PA more clearly could be an option. When
bronchial sleeve resection is needed, we prefer to protect
the bronchial anastomosis by intercostal muscle flap. It
can act as a buffer between PA and bronchus, and this
buffer should not be too thick. That would elevate pul-
monary artery too high and reduce the blood inflow.
We found that tumor or metastatic lymph nodes lo-
cated in the lower or middle lobe occasionally just in-
vaded the upper lobe along the interlober PA. The upper
lobe could be preserved as long as a clean arterial mar-
gin could be achieved below the level of the 1st branch
(apical and anterior branches) of the pulmonary artery.
Complications occurred in 3 out of 6 (50%). They are
empyema (n = 1 because of his nephron syndrome),
pneumonia (n = 1), and transient atria fibrillation (n = 1).
2 lived more than 5 years, 1 died of myocardial infarc-
tion 2 years later, one died of brain metastasis 3 years
later and 1 died of respiratory failure 18 months later.
One was lost during follow-up. No other authors have
reported this kind of technique before. In our limited ex-
perience of these 6 patients, the upper lobe can be pre-
served with this viable option. The blood supply for the
upper lob is sufficient just relying on the 1st branch of
pulmonary artery. Patients had better postoperative pul-
monary function and improved quality of life. However,
Table 2 Multivariate analysis for 5-year survival
Variable Hazard ratio P value
Gender Male vs. female 1.781 0.0978
Stage III vs. I&II 2.819 0.0012
Histologic type Non-squamous cell carcinoma Vs. squamous cell carcinoma 4.536 0.0007
Procedure PA reconstruction associated with bronchial sleeve resection vs. not 0.203 <0.0001
Reconstruction technique of PA Patch vs. tangential 2.138 0.0208
Sleeve vs. tangential 0.798 0.6357
Truncus preserved vs. tangential 0.175 0.1200
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outcome. The temporary intra-artery conduit technique
brought us some conveniences and the patients can re-
cover faster with lower cost. Nevertheless, the potential
higher risks in thesis cases are not insubstantial. We
only utilize this technique when the circumferential en-
croachment of the main PA is less than 20%. And CPB
should be prepared before and during the operation.
The incidence of complications in our study was
52.2% and was associated with older age (p < 0.0001),
Stage III disease (p < 0.0001), induction chemotherapy
(p < 0.0001), non-squamous cell carcinoma (p = 0.0006),
N2 status (p < 0.0001) and PA extended resection with
bronchus sleeve resection (p < 0.0001). Concern about
high postoperative complications limited the acceptance
of the PA angioplasty [10]. In fact, they are companied
with the operation and most of them can be controlled
with medication successfully without influence of the
5-year survival. How the incidence of complications sig-
nificantly predict recurrence was uncertain to the authors.
It is possible that the development of complications is a
surrogate for patients with more extensive disease (not
captured by the staging system), for example, more prox-
imal tumors or magnitude of N1 adenopathy. In these pa-
tients, the resection is more difficult, which may lead to a
higher complication rate, and the recurrence rate (local
and regional) might also be higher. This finding only
suggests an association between these two events—not
that patients should not have undergone resection—but
whether surgical complication caused recurrence is an-
other question to be tested in future studies.
The estimated 5-year survival rate was 50.2%, which is
consistent with that reported for standard resection [11].
The results from the present study suggest that stage III,
histology type of non-squamous cell carcinoma and
patch pulmonary arterioplasty are prominently prognos-
tically related. The 5-year survival for stage III is signifi-
cantly lower than stage I and II. Although it is more
technical demanding after chemotherapy and/or radi-
ation therapy, reconstruction of PA can be carried out
safely. So we recommend induction and/or radiation
therapy first for the patients with stage III, and thosewho are proved down-staged would be selected for surgi-
cal candidates. Those who progress through therapy are
clearly not going to benefit from resection and should be
considered inoperable. Decision of operation for patients
who had no change after induction is complex. The bene-
fits of resection and benefits of non-operative therapy
should be carefully deliberated in multi-disciplinary tumor
board and informed to the patents.
Non-squamous cell carcinoma showed more aggressive
biological character and generally disseminates outside the
thorax somewhat earlier than squamous cell carcinoma.
These patients should be considerate as a different group
and treated separately. Tineke W.H. Meijera and his col-
leagues found this was due to the difference in metabol-
ism. Adenocarcinomas may use aerobic glycolysis as an
energy source, whereas the metabolism of squamous cell
carcinomas seems to rely on mitochondrial oxidation with
anaerobic glycolysis under hypoxic conditions. Aerobic
glycolytic metabolism is an additive responsible factor for
aggressive behavior in NSCLC [11]. This subgroup of tu-
mors may try new treatment approaches first, such as
MCT4 inhibitors, and then consider surgery.
When considering appropriate surgical technique,
careful examination and precise evaluation of the extent
of PA involvement is critical. Errors should be avoided
when choosing reconstruction techniques. The goal of
the angioplasty was to obtain a suitable length of PA
and smooth lumen. Tension and bleeding were prob-
ably resulted from inadequate artery length. On the
other hand, the axis of PA was more easily twisted due
to unnecessary preservation. The vessel twist might im-
pair the blood flow and lead to the stenosis or throm-
bosis. When upper lobectomy was performed, more
attention should be paid to avoid the kinking because
of elevation of the lower lobe. Autologous pericardial
patch can exceed the length of PA, and there is no pos-
terior suture line on the artery, which can be a buffer
against the bronchial stump or anastomosis. However,
it is difficult to harvest patches with suitable size. Be-
cause it was hard to estimate how much the graft will
stretch, shrink kinking or turbulence after the artery
was reexpanded [12].
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patients 24 hours after PA plasty. This 24 hours’ time
window was used to observe the volume and character
of chest drainage to exclude post-operative hemothorax.
High-risk patients included hypertension, coronary ath-
erosclerosis, and more than 50 years old. Contraindica-
tions are the volume of chest bloody drainage per day is
more than 200 ml, peptic ulcer, trend of stoke and al-
lergy to aspirin. In this study, stents or grafts were not
used, so we did not have experience of other anti-
platelet like clopidogrel. For the issue of preventing pul-
monary embolism, Heparin lock flush solution (12500 u
diluted with 500 ml sodium chloride solution) was used
during operation. Considering the pulmonary artery
blood flow was broken off when proximal and distal
parts of the PA were both controlled, intravenous heparin
sodium (1 mg/kg) was used when applying autologous
pericardial patch or circumferential resection.
Complete resection and long-term survival are mainly
affected by neoplastic events. PA reconstruction associated
with bronchial sleeve resection is a positive prognostic fac-
tor in our study. This can be expained by more complete
resection percentage and lower risk of recurrence. The
study also shows that PA invasions are more longitudinal
and circumferential for the patients who received patch
angioplasty. Their 5-year survivals are significantly lower
than others.
Conclusion
The retrospective study method, different preoperative
status and heterogeneous of stage, nodal and histology are
limitations of this study. We cannot draw some confirma-
tive conclusions. Nevertheless, we do not found local re-
currence at the level of the PA angioplasty or other
oncological or technical drawbacks. The early and long-
term results suggest that these surgical techniques of PA
reconstruction are feasible and safe, and the postoperative
morbidity is also acceptable. Stage I and II and those who
are proved down-staged from stage III should be selected
for surgical candidates. It is reasonable to apply this tech-
nique more liberally as long as R0 resection is achieved,
regardless of pulmonary function.
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